Down syndrome Alzheimer's disease Medial septum Spatial memory Stereology Hippocampus Radial arm water maze Vertical limb of the diagonal band Nucleus basalis Down syndrome (DS) is marked by intellectual disability (ID) and early-onset of Alzheimer's disease (AD) neuropathology, including basal forebrain cholinergic neuron (BFCN) degeneration. The present study tested the hypothesis that maternal choline supplementation (MCS) improves spatial mapping and protects against BFCN degeneration in the Ts65Dn mouse model of DS and AD. During pregnancy and lactation, dams were assigned to either a choline sufficient (1.1 g/kg choline chloride) or choline supplemented (5.0 g/kg choline chloride) diet. Between 13 and 17 months of age, offspring were tested in the radial arm water maze (RAWM) to examine spatial mapping followed by unbiased quantitative morphometry of BFCNs. Spatial mapping was significantly impaired in unsupplemented Ts65Dn mice relative to normal disomic (2N) littermates. Additionally, a significantly lower number and density of medial septum (MS) hippocampal projection BFCNs was also found in unsupplemented Ts65Dn mice. Notably, MCS significantly improved spatial mapping and increased number, density, and size of MS BFCNs in Ts65Dn offspring. Moreover, the density and number of MS BFCNs correlated significantly with spatial memory proficiency, providing support for a functional relationship between these behavioral and morphometric effects of MCS for trisomic offspring. Thus, increasing maternal choline intake during pregnancy may represent a safe and effective treatment approach for expectant mothers carrying a DS fetus, as well as a possible means of BFCN neuroprotection during aging for the population at large.
Down syndrome (DS) is marked by intellectual disability (ID) and early-onset of Alzheimer's disease (AD) neuropathology, including basal forebrain cholinergic neuron (BFCN) degeneration. The present study tested the hypothesis that maternal choline supplementation (MCS) improves spatial mapping and protects against BFCN degeneration in the Ts65Dn mouse model of DS and AD. During pregnancy and lactation, dams were assigned to either a choline sufficient (1.1 g/kg choline chloride) or choline supplemented (5.0 g/kg choline chloride) diet. Between 13 and 17 months of age, offspring were tested in the radial arm water maze (RAWM) to examine spatial mapping followed by unbiased quantitative morphometry of BFCNs. Spatial mapping was significantly impaired in unsupplemented Ts65Dn mice relative to normal disomic (2N) littermates. Additionally, a significantly lower number and density of medial septum (MS) hippocampal projection BFCNs was also found in unsupplemented Ts65Dn mice. Notably, MCS significantly improved spatial mapping and increased number, density, and size of MS BFCNs in Ts65Dn offspring. Moreover, the density and number of MS BFCNs correlated significantly with spatial memory proficiency, providing support for a functional relationship between these behavioral and morphometric effects of MCS for trisomic offspring. Thus, increasing maternal choline intake during pregnancy may represent a safe and effective treatment approach for expectant mothers carrying a DS fetus, as well as a possible means of BFCN neuroprotection during aging for the population at large. © 2014 Elsevier Inc. All rights reserved.
Introduction
Down syndrome (DS), caused by triplication of human chromosome 21 (HSA21), is the most common genetic disorder resulting in intellectual disability (ID). By the third or fourth decade of life, DS individuals develop dementia and the histopathological characteristics of Alzheimer's disease (AD) (Casanova et al., 1985; Fodale et al., 2006; Mann, 1988; Mann and Esiri, 1989; Mann et al., 1984 Mann et al., , 1986 Wisniewski et al., 1985a Wisniewski et al., , 1985b , including neurofibrillary tangles, neuritic plaques, and cholinergic basal forebrain pathology (Isacson et al., 2002; Mufson et al., 2003; Sendera et al., 2000; Whitehouse et al., 1982) . Currently, there are no therapeutic interventions that prevent or reverse ID, age-related cognitive impairment, or brain pathology in DS.
Several mouse models have been developed to study the relationship between the triplication of specific genes in DS and distinct phenotypic features (see Das and Reeves, 2011; Rueda et al., 2012; Salehi et al., 2006 for reviews). The most well-characterized animal model is the Ts65Dn mouse, which is segmentally trisomic for the distal region of mouse chromosome 16 (MMU16) which contains more than 100 highly conserved genes that are orthologous to those on HSA21 (Sturgeon and Gardiner, 2011) . This triplicated chromosomal segment also includes the "Down syndrome critical region," (DSCR) which is considered necessary, although not solely sufficient, for the DS phenotype (Belichenko et al., 2009; Olson et al., 2004 Olson et al., , 2007 .
Similar to humans with DS, Ts65Dn mice are born with an intact basal forebrain cholinergic neuron (BFCN) system, which undergoes 
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